Studies have shown that AAMP is overexpressed in non‐small cell lung cancer (NSCLC), breast cancer, gastric cancer, and other malignancies10 with its high expression closely associated with tumor malignancy, metastatic potential, and patient prognosis.7 The gene discussed is AAMP; the disease is neoplasm.